Is EVO or FHTX more undervalued in 2026?

CirclFi compares Evotec SE (EVO) and Foghorn Therapeutics Inc. (FHTX) using 13 institutional-grade valuation models. EVO has a Quality of Company score of 6.2/10 while FHTX scores 6.3/10.

Which is a better buy — EVO or FHTX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do EVO and FHTX valuations compare?

EVO at $3.07 and FHTX at $4.28 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

EVO vs FHTX Valuation Comparison 2026 — Intrinsic Value Analysis

EVO

Pharmaceutical Preparations

Evotec SE

Quality

6.2

out of 10

Value Trap

SAFE

Price

$3.07

Last close

Models

10/13

Active

FHTX

Pharmaceutical Preparations

Foghorn Therapeutics Inc.

Quality

6.3

out of 10

Value Trap

SAFE

Price

$4.28

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	EVO Fair Value	EVO Upside	FHTX Fair Value	FHTX Upside
Bayesian DCF	Intrinsic	$0.22	-92.8%	$1.29	-69.8%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$1.13	-63.1%	$0.56	-86.9%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$0.87	-71.6%	$8.04	+87.9%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for EVO vs FHTX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

EVO vs FHTX — Which Stock Is More Undervalued?

FHTX scores higher with a 6.3/10 quality rating vs EVO's 6.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Evotec SE (EVO) and Foghorn Therapeutics Inc. (FHTX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

EVO currently trades at $3.07 with a QOC of 6.2/10, while FHTX trades at $4.28 with a QOC of 6.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).